Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New tyrosine kinase inhibitors, their preparation and use covered by Merck patent

Dec. 19, 2003

Sosei and Nippon Organon to copromote SOT-375 in Japan

Dec. 18, 2003

Efficacy and safety of lonafarnib in hematological tumors

Dec. 18, 2003

Antitumor effects of CCI-779 in multiple myeloma and MCL

Dec. 18, 2003

Phase I trial of topotecan TCS delayed until Q3 2004

Dec. 18, 2003

New findings on structure and function of prostate-specific membrane antigen

Dec. 17, 2003

Valera files Vantas NDA

Dec. 17, 2003

Independent committee recommends early end to phase III Velcade trial

Dec. 17, 2003

Japanese rights to bevacizumab and pertuzumab licensed to Chugai

Dec. 17, 2003

Targent acquires dibromodulcitol

Dec. 17, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 6, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...